Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth M Steinberg

Showing results (271-280 of 481) with videos related to

Pageof 49
Sort By:
BJU International|August 20, 2008
Association of the ABCG2 C421A polymorphism with prostate cancer risk and survivalErin R Gardner, Christoph M Ahlers, Suneet Shukla, et al.
Leukemia & Lymphoma|July 16, 2005
Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphomaYouli Zu, Seth M Steinberg, Elias Campo, et al.
Leukemia & Lymphoma|December 16, 2006
Very high-dose methotrexate (33.6 g/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144PPaul C Nathan, Trish Whitcomb, Pamela L Wolters, et al.
Cancer Medicine|December 8, 2025
A Phase II Pilot Study of Anti-PD-L1, Durvalumab, and a PARP Inhibitor, Olaparib in Patients With Metastatic Triple-Negative Breast Cancer With or Without Germline BRCA MutationTakeo Fujii, Ashley Cimino-Mathews, Stanley Lipkowitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleuraDavid S Schrump, Maria R Fischette, Dao M Nguyen, et al.
Nature Reviews. Cancer|January 26, 2007
Compressing drug development timelines in oncology using phase '0' trialsShivaani Kummar, Robert Kinders, Larry Rubinstein, et al.
Cancer Research|October 7, 2004
Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastomaJun S Wei, Braden T Greer, Frank Westermann, et al.
Blood Advances|July 24, 2023
A comprehensive analysis of adverse events in the first 30 days of phase 1 pediatric CAR T-cell trialsSara K Silbert, Sanna Madan, Elizabeth M Holland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2016
Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric SarcomasMelinda S Merchant, Donna Bernstein, Martha Amoako, et al.
The Lancet. Oncology|February 14, 2012
Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trialRavi A Madan, Mahsa Mohebtash, Philip M Arlen, et al.
Pageof 49

Showing results (271-280 of 481) with videos related to

Sort By:
Pageof 49
BJU International|August 20, 2008
Association of the ABCG2 C421A polymorphism with prostate cancer risk and survivalErin R Gardner, Christoph M Ahlers, Suneet Shukla, et al.
Leukemia & Lymphoma|July 16, 2005
Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphomaYouli Zu, Seth M Steinberg, Elias Campo, et al.
Leukemia & Lymphoma|December 16, 2006
Very high-dose methotrexate (33.6 g/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144PPaul C Nathan, Trish Whitcomb, Pamela L Wolters, et al.
Cancer Medicine|December 8, 2025
A Phase II Pilot Study of Anti-PD-L1, Durvalumab, and a PARP Inhibitor, Olaparib in Patients With Metastatic Triple-Negative Breast Cancer With or Without Germline BRCA MutationTakeo Fujii, Ashley Cimino-Mathews, Stanley Lipkowitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleuraDavid S Schrump, Maria R Fischette, Dao M Nguyen, et al.
Nature Reviews. Cancer|January 26, 2007
Compressing drug development timelines in oncology using phase '0' trialsShivaani Kummar, Robert Kinders, Larry Rubinstein, et al.
Cancer Research|October 7, 2004
Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastomaJun S Wei, Braden T Greer, Frank Westermann, et al.
Blood Advances|July 24, 2023
A comprehensive analysis of adverse events in the first 30 days of phase 1 pediatric CAR T-cell trialsSara K Silbert, Sanna Madan, Elizabeth M Holland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2016
Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric SarcomasMelinda S Merchant, Donna Bernstein, Martha Amoako, et al.
The Lancet. Oncology|February 14, 2012
Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trialRavi A Madan, Mahsa Mohebtash, Philip M Arlen, et al.
Pageof 49